Delivery Order SPE2DR25D3004-SPE2DR26FXNU8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,956.49 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,744.44 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pen (0.5 ml), a diabetes medication. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of December 2, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and military healthcare systems. The place of performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,336.89 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pen (0.5 ml), a brand-name diabetes medication. This firm fixed-price delivery order, awarded on August 13, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 14, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,970.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and carries firm fixed pricing with no set-aside designation. The award represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle with DLA, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order valued at $4,410.60 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen (0.5 ml), a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on November 20, 2025, with an ultimate completion date of November 21, 2025. The award was fulfilled from the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,386.78 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pen (0.5 mL), a diabetes medication. This non-competitive, firm fixed-price delivery order was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,744.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This firm fixed price delivery order, issued on December 5, 2025, with completion targeted for December 8, 2025, represents a non-competitive award under a larger contract vehicle. The pharmaceutical products will be delivered to support federal healthcare operations, with AmerisourceBergen's place...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,759.08 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL), a diabetes medication. This competitively awarded, firm fixed-price delivery order was finalized on November 18, 2025, with completion expected by November 19, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to...
- The Defense Logistics Agency awarded a delivery order valued at $4,025.74 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The contract has an ultimate completion date of November 26, 2025, and AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,825.70 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pen (0.5 ml), a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract is not set-aside and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXNU8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,201.66 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen (0.5 ml), a diabetes medication. This firm fixed-price delivery order, issued on December 2, 2025, with completion targeted for December 3, 2025, was not set-aside and was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems worldwide. The company's extensive contract portfolio with DLA reflects its capability to fulfill federal pharmaceutical procurement requirements across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/1/25 |